GOALS & OBJECTIVES
Beyond Quality of Life: Advances in the Understanding and Treatment of Mucositis in Patients Undergoing HSCT
Paper Symposium
Activity Date: April 2005  — Activity Info: Volume5, (4B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide bone marrow transplant clinicians with up-to-date information on the diagnosis and treatment of patients with mucositis.

TARGET AUDIENCE
This activity is designed for bone marrow transplant clinicians. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, the participant should be able to:

  • Describe the epidemiology and pathophysiology of oral and gastrointestinal mucositis.
  • Provide healthcare providers with information regarding current treatment options, including cryotherapy, topical and systemic antimicrobial agents, biologic mucosal protectants, and laser therapy.
  • Indicate the future directions for treatment options, such as human keratinocyte growth factor 1, recombinant human keratinocyte growth factor 2, L-glutamine, and iseganan.
  • Review the clinical relevance and applicability of the Clinical Practice Guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Tennessee College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award.

This program is approved for 2 hours (0.2 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the American Council on Pharmacy Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-999-05-201-H01.

Each participant should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 2 hours.

Release date: April 15, 2005. Expiration date: April 15, 2007.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine, and the University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an educational grant from Amgen, Inc.

     
Home | Contact Us | View Account | Need Help?